J Studios/DigitalVision via Getty Images Eli Lilly Investment Overview Eli Lilly ( LLY ) has cemented its status as the world's leading pharmaceutical company as it produced a stellar set of Q1 2026 earnings. The Indianapolis based company delive red r evenues of $19.8bn, up a staggering 56% year-on-year, while its
J Studios/DigitalVision via Getty Images Eli Lilly Investment Overview Eli Lilly ( LLY ) has cemented its status as the world's leading pharmaceutical company as it produced a stellar set of Q1 2026 earnings. The Indianapolis based company delive red r evenues of $19.8bn, up a staggering 56% year-on-year, while its
CNBC's Jim Cramer said Meta Platforms ' post-earnings decline isn't a reason to jump ship on the stock. Shares are headed for their worst session in six months after a spending outlook raise sent the Facebook parent down over 9% Thursday. Still, Cramer remains a firm believer in CEO Mark Zuckerberg's vision for the company. "My Charitable Trust has faith in him," Cramer said during "Squawk on the ...
CNBC's Jim Cramer said Meta Platforms ' post-earnings decline isn't a reason to jump ship on the stock. Shares are headed for their worst session in six months after a spending outlook raise sent the Facebook parent down over 9% Thursday. Still, Cramer remains a firm believer in CEO Mark Zuckerberg's vision for the company. "My Charitable Trust has faith in him," Cramer said during "Squawk on the Street." "We have faith in Zuckerberg." After all, there have been several times where Wall Street soured on Meta over the years but the stock still managed to bounce back. Zuckerberg's massive metaverse costs and company-wide rebrand in 2022? It led to Meta's worst year ever. But the stock staged a multi-year comeback, starting in 2023 after management changed its strategy to focus on the "year of efficiency ." META YTD mountain Meta Platforms YTD Cramer understands why investors are concerned. Meta's ramped up its generative artificial intelligence spending so much over the past year. Although management reiterated Meta's 2026 total expense guidance, the tech behemoth hiked its capital expenditures by $10 billion at the midpoint. Making matters worse, Bloomberg News reported that Meta is looking to raise up to $25 billion through a bond sale to fund its AI expansion even further. "Meta's got some thinking to do," Cramer said. "They're like the Treasury. They have to finance every quarter." Unlike its Big Tech counterparts, Meta do not have a cloud. Amazon, Microsoft, and Alphabet — which all reported earnings Wednesday evening, too — are the three biggest clouds in that order. Higher spending guides have been easier forgiven for the clouds, as evidenced by Alphabet shares jumping nearly 7% on Thursday. Still, Meta deserves some credit for beats on the top and bottom line, with strong numbers from its advertising business. "Let's give Meta some due," he added. "It did have a great acceleration in its advertising." It's also just another reason why his Charitable Trust – th...
In this article HSY Follow your favorite stocks CREATE FREE ACCOUNT Packages of Ice Breakers spearmint mints Mints are displayed at a Costco Wholesale store on April 27, 2025 in San Diego, California. Kevin Carter | Getty Images Hershey is seeing higher sales for its mints and gum — thanks to the growing use of GLP-1 drugs. "We've also seen strong demand for gum and mints, as the category benefits...
In this article HSY Follow your favorite stocks CREATE FREE ACCOUNT Packages of Ice Breakers spearmint mints Mints are displayed at a Costco Wholesale store on April 27, 2025 in San Diego, California. Kevin Carter | Getty Images Hershey is seeing higher sales for its mints and gum — thanks to the growing use of GLP-1 drugs. "We've also seen strong demand for gum and mints, as the category benefits from functional snacking tailwinds, including GLP-1 adoption," CEO Kirk Tanner said in pre-recorded remarks ahead of the company's earnings conference call Thursday. "Retails sales for our third-largest confection brand, Ice Breakers, increased over 8% in the quarter." While Tanner didn't specify why the increasing usage of GLP-1 agonists fueled mint and gum sales, some people who take medications like Ozempic, Wegovy and Mounjaro report experiencing halitosis, or bad breath. However, so-called Ozempic breath is not an official listed side effect for the medication. Dental experts have linked the drugs to dry mouth, likely caused by dehydration and changes to saliva caused by the medication. Hershey isn't the only company known for its sweet treats that is reporting a surprising lift in sales from GLP-1 users. Swiss chocolatier Lindt & Spruengli said in March that U.S. sales of premium chocolate rose faster last year among people using the medication than those who weren't. And The Magnum Ice Cream Company told investors that data suggests that the growing adoption of GLP-1 drugs will likely boost sales of its more expensive products, like those that come in smaller portions or offer more protein or contain real fruit. It called the trend "the premium treat substitution effect." "As consumers using GLP-1s are eliminating [the] low-quality munching categories first, categories like premium chocolate, premium ice cream and protein snacks could gain share in the overall snacking market," CEO Peter ter Kulve said on the company's earnings conference call in February. The boost...
American nearly lost leg after crash at Winter Games 41-year-old does not rule out return to racing Lindsey Vonn says she is still recovering physically and emotionally from her crash at the Winter Olympics and does not know when, or if, she will race again. The 41-year-old has undergone eight surgeries after suffering a complex left leg fracture – one that nearly led to a leg amputation – in the ...
American nearly lost leg after crash at Winter Games 41-year-old does not rule out return to racing Lindsey Vonn says she is still recovering physically and emotionally from her crash at the Winter Olympics and does not know when, or if, she will race again. The 41-year-old has undergone eight surgeries after suffering a complex left leg fracture – one that nearly led to a leg amputation – in the women’s downhill in February. She needs at least one more operation to repair a torn ACL in the same knee. Continue reading...
According to a Securities and Exchange Commission (SEC) filing dated April 28, 2026, MBL Wealth, LLC increased its holding in iShares Trust - iShares Core 1-5 Year USD Bond ETF (NASDAQ:ISTB) by 60,258 shares. The estimated transaction value was $2.94 million, based on the average unadjusted closing price during the first quarter of 2026. The quarter-end position value increased by $2.70 million fr...
According to a Securities and Exchange Commission (SEC) filing dated April 28, 2026, MBL Wealth, LLC increased its holding in iShares Trust - iShares Core 1-5 Year USD Bond ETF (NASDAQ:ISTB) by 60,258 shares. The estimated transaction value was $2.94 million, based on the average unadjusted closing price during the first quarter of 2026. The quarter-end position value increased by $2.70 million from the prior period, reflecting both share purchases and price changes. The iShares Core 1-5 Year USD Bond ETF offers investors efficient access to a diversified portfolio of short-term U.S. dollar-denominated bonds. With an asset base of $4.74 billion, the fund is structured to deliver stable income and moderate risk through broad fixed income exposure. Its competitive yield and low expenses make it an attractive core holding for those seeking income and risk mitigation in a rising or uncertain rate environment. Investors seeking steady income in an uncertain interest rate environment might find the iShares Core 1-5 Year USD Bond ETF as attractive as MBL Wealth. Its short-term bond strategy isn’t as sensitive to fluctuating interest rates as strategies that target longer durations. Continue reading
PTT Exploration and Production Public Company Limited press release ( PEXNY ): Q1 GAAP EPS of $0.09. Revenue of $2.49B. More on PTT Exploration and Production Public Company Limited PTT Exploration and Production Public Company Limited (PEXNY) Presents at Opportunity Day Quarter 4/ FY 2025 - Slideshow PTT Exploration and Production Public Company Limited 2025 Q4 - Results - Earnings Call Presentat...
PTT Exploration and Production Public Company Limited press release ( PEXNY ): Q1 GAAP EPS of $0.09. Revenue of $2.49B. More on PTT Exploration and Production Public Company Limited PTT Exploration and Production Public Company Limited (PEXNY) Presents at Opportunity Day Quarter 4/ FY 2025 - Slideshow PTT Exploration and Production Public Company Limited 2025 Q4 - Results - Earnings Call Presentation Historical earnings data for PTT Exploration and Production Public Company Limited Dividend scorecard for PTT Exploration and Production Public Company Limited Financial information for PTT Exploration and Production Public Company Limited
CHENG FENG CHIANG/iStock Editorial via Getty Images Siemens ( SIEGY ) said Thursday it received an order worth ~2B Swiss francs ($2.53B) for double-deck trains from Swiss rail operator SBB. The contract calls for the delivery of 116 six-car Desiro DoSto double-deck trains, along with an option for as many
CHENG FENG CHIANG/iStock Editorial via Getty Images Siemens ( SIEGY ) said Thursday it received an order worth ~2B Swiss francs ($2.53B) for double-deck trains from Swiss rail operator SBB. The contract calls for the delivery of 116 six-car Desiro DoSto double-deck trains, along with an option for as many
Belgian is fourth lowest-ranked player to reach last four Injured Alcaraz turns up to support young brother Jamie Alexander Blockx’s dream run in Madrid continues with the 21-year-old Belgian beating the defending champion Casper Ruud 6-4, 6-4 in the quarter-finals of the Madrid Open on Thursday. The 69th-ranked emerging talent had not won an ATP Tour match on clay before his third-round run in Mo...
Belgian is fourth lowest-ranked player to reach last four Injured Alcaraz turns up to support young brother Jamie Alexander Blockx’s dream run in Madrid continues with the 21-year-old Belgian beating the defending champion Casper Ruud 6-4, 6-4 in the quarter-finals of the Madrid Open on Thursday. The 69th-ranked emerging talent had not won an ATP Tour match on clay before his third-round run in Monte Carlo three weeks ago. He has also defeated the third-seeded Felix Auger-Aliassime and Francisco Cerundolo on his way to the last four in the Spanish capital. Continue reading...
mohd izzuan Shares of Option Care Health ( OPCH ) reached the lowest level in nearly five years after the infusion services provider's top line for Q1 2026 missed Street forecasts and the company lowered its full-year revenue outlook, citing lackluster growth. CEO John Rademacher
mohd izzuan Shares of Option Care Health ( OPCH ) reached the lowest level in nearly five years after the infusion services provider's top line for Q1 2026 missed Street forecasts and the company lowered its full-year revenue outlook, citing lackluster growth. CEO John Rademacher
Microsoft appears bound for a bounce as its latest quarterly report shows signs its artificial intelligence strategy will power revenue higher in the future, according to several analysts on Wall Street. The software giant earned $4.27 per share after adjustments in the fiscal third quarter quarter, topping the $4.06 per share expected by analysts surveyed by LSEG. Its revenue came in at $82.89 bi...
Microsoft appears bound for a bounce as its latest quarterly report shows signs its artificial intelligence strategy will power revenue higher in the future, according to several analysts on Wall Street. The software giant earned $4.27 per share after adjustments in the fiscal third quarter quarter, topping the $4.06 per share expected by analysts surveyed by LSEG. Its revenue came in at $82.89 billion, outpacing the consensus estimate of $81.39 billion. Despite the stronger-than-expected report , shares declined nearly 5% in Thursday's session. One concern is rising spending. Microsoft expects its capital expenditures to balloon to $190 billion by the end of this year due to surging memory costs. Investors also are skeptical about the pace of its future growth. However, some analysts found evidence to be more bullish on the stock. "We see this quarter as a meaningful first step in reversing the stock's multi-quarter period of underperformance as Microsoft disclosed several milestones to directly address medium-term investor concerns," Goldman Sachs analyst Gabriela Borges said Thursday in a note to clients. She cited accelerating revenue growth at its Azure and Microsoft 365 businesses, its evolving pricing model and the tangible data the company shared for her view. Borges has a buy rating on Microsoft with a $610 price target on its shares, implying 44% upside from Wednesday's close. Microsoft is fresh off its worst quarterly performance since 2008, largely due to investors' concerns that the traditionally software-focused stock could be battered by AI disruption. However, the firm unveiled a new corporate strategy embracing AI in 2024, and it is showing signs of making meaningful advances in that realm, with its cloud-computing business accelerating in the latest reported quarter. "We are constructive on Microsoft's positioning in the AI ecosystem and see a catalyst-rich path in 2H," Borges said. Here's what shops on the Street are saying about Microsoft followi...
Investing.com -- Goldman Sachs is standing behind Microsoft following the company's third-quarter fiscal results, maintaining a buy rating and a 12-month price target of $610 on the stock, even as shares trade lower on Thursday.
Investing.com -- Goldman Sachs is standing behind Microsoft following the company's third-quarter fiscal results, maintaining a buy rating and a 12-month price target of $610 on the stock, even as shares trade lower on Thursday.
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Ross Stores is now the #32 analyst pick, moving up by 2 spots. This rank is formed by averaging the analyst opinions for each component from ea
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Ross Stores is now the #32 analyst pick, moving up by 2 spots. This rank is formed by averaging the analyst opinions for each component from ea